Apogee Therapeutics, Inc. (NASDAQ:APGE)
| Market Cap | 8.36B+239.2% |
| Revenue (ttm) | 0 |
| Net Income | -294.37M-23.9% |
| EPS | -4.34-4.3% |
| Shares Out | 62.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 0 |
| Open | 135.07 |
| Previous Close | 135.07 |
| Day's Range | 135.07 - 135.07 |
| 52-Week Range | 35.39 - 135.09 |
| Beta | 0.34 |
| Analysts | Hold |
| Price Target | 130.92(-3.07%) |
| Earnings Date | Nov 9, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About APGE
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$APGE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in APGE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by APGE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
APGE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New APGE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to APGE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in APGE
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $252.40M |
| VBVanguard Morningstar Small-Cap ETF | $93.78M |
| VXFVanguard Extended Market ETF | $87.78M |
| VBRVanguard Morningstar Small-Cap Value ETF | $58.04M |
| VTWOVanguard Russell 2000 ETF | $35.01M |
| VHTVanguard Health Care ETF | $19.13M |
Estimated from each fund’s disclosed top holdings × AUM
APGE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from APGE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score